Table 1. Age-related changes in ECM components and potential effects on tumor progression.
Promoting | Inhibiting | |
---|---|---|
Collagen I | Increased stiffness | Decreased synthesis/density Increased fragmentation |
Laminin | Cleavage and/or loss of LM332 (α3β3γ2) Increased expression of LM α4 and β1 chains |
LM332 (α3β3γ2) expression with polarization of epithelial cells Increased expression of LM α4 and β2 chains |
TSP1 | Long term interactions with VEGF | Increased expression– inhibition of angiogenesis via multiple mechanisms |
SPARC | Interactions with Collagen I synthesis and processing Cleavage into pro-angiogenic forms |
Increased expression– inhibition of GF effects on endothelial cells |
Hyaluronan | Increases in total Hyaluronan | Decrease in HA turnover/generation of LMW-HA forms |